HealthSupreme Court Criticizes High Mark-Ups on Cancer Drug Prices
On September 29, 2026, the Supreme Court expressed concern over the large price differences between retailer and consumer prices for essential medicines, especially cancer drugs. The Court questioned why the 16% retailer margin under the Drugs (Prices Control) Order, 2013, is not uniformly applied to all essential medicines. Justices Vikram Nath and Sandeep Mehta called the steep mark-ups a burden on taxpayers and described the situation as "carnage."
Hindu Health·2h ago·New Delhi



